Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 3 March 2014 |
| Author/s |
author: Antonino Maiorana Enrico Tagliafico Stefania Bettelli Federico Piacentini |
| Publication date | March 3, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |